T-bet controls intestinal mucosa immune responses via repression of type 2 innate lymphoid cell function. (2019)

First Author: Garrido-Mesa N
Attributed to:  MICA: Targeted Regulatory T Cell Therapy for Inflammatory Bowel Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41385-018-0092-6

PubMed Identifier: 30356098

Publication URI: http://europepmc.org/abstract/MED/30356098

Type: Journal Article/Review

Volume: 12

Parent Publication: Mucosal immunology

Issue: 1

ISSN: 1933-0219